XML 41 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
INCOME TAXES
12 Months Ended
Jun. 30, 2017
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
(Loss) income from operations before income taxes in fiscal 2017, 2016 and 2015 is presented below:
 
Year Ended June 30,

2017
 
2016
 
2015
United States
$
(524.8
)
 
$
(153.6
)
 
$
(173.7
)
Foreign
(133.2
)
 
292.4

 
407.0

Total
$
(658.0
)
 
$
138.8

 
$
233.3


The components of the Company’s total (benefit) provision for income taxes during fiscal 2017, 2016 and 2015 are presented below:
 
Year Ended June 30,

2017
 
2016
 
2015
(Benefit) provision for income taxes:
 
 
 
 
 
Current:
 
 
 
 
 
Federal
$
0.4

 
$
(30.0
)
 
$
3.7

State and local
1.1

 
(2.7
)
 
3.3

Foreign
129.0

 
131.5

 
54.1

Total
130.5

 
98.8

 
61.1

Deferred:
 
 
 
 
 
Federal
(256.9
)
 
(91.7
)
 
(71.0
)
State and local
(24.2
)
 
(9.9
)
 
(12.0
)
Foreign
(108.9
)
 
(37.6
)
 
(4.2
)
Total
(390.0
)
 
(139.2
)
 
(87.2
)
Benefit for income taxes
$
(259.5
)
 
$
(40.4
)
 
$
(26.1
)

During the second quarter of fiscal 2017, the Company released a valuation allowance in the U.S. as a result of the P&G Beauty Business acquisition of $111.2.
During the first quarter of fiscal 2016, the Company reached final settlement with the IRS in connection with the 2004–2012 examination periods. The settlement primarily relates to the acquisition of the Calvin Klein fragrance business. In connection with the settlement, the Company recognized a tax benefit of approximately $194.4 of which $164.7 was mainly due to the recognition of additional deferred tax assets related to the basis of the Calvin Klein trademark, and approximately $29.7 resulted from the reduction of gross unrecognized tax benefits. Of the $194.4 tax benefit, $111.2 was offset by a valuation allowance due to on-going operating losses in the U.S.
During fiscal 2015, the Company transferred certain international intellectual property rights to its wholly-owned subsidiary in Switzerland in order to align the Company’s ownership of these international intellectual property rights with its global operations.  Although the transfer of foreign intellectual property rights between consolidated entities did not result in any gain in the consolidated results of operations, the Company generated a taxable gain in the U.S. that was offset by net operating loss carryforwards.  Income taxes incurred related to the intercompany transactions are treated as a prepaid income tax in the Company’s consolidated balance sheet and amortized to income tax expense over the life of the intellectual property. For the fiscal years ending June 30, 2017 and 2016, the prepaid income taxes of $7.6 and $7.6, respectively, are included in Prepaid expenses and other current assets and $128.2 and $135.8, respectively, are included in Other noncurrent assets in the Consolidated Balance Sheets. The prepaid income taxes are amortized as a component of income tax expense over twenty years.
The reconciliation of the U.S. Federal statutory tax rate to the Company’s effective income tax rate during fiscal 2017, 2016 and 2015 is presented below:
 
Year Ended June 30,

2017
 
2016
 
2015
Income (loss) before income taxes
$
(658.0
)
 
$
138.8

 
$
233.3

(Benefit) provision for income taxes at statutory rate
$
(230.3
)
 
$
48.5

 
$
81.7

State and local taxes—net of federal benefit
(15.0
)
 
(8.3
)
 
(5.6
)
Foreign tax differentials
53.3

 
(50.8
)
 
(74.4
)
Change in valuation allowances
(108.2
)
 
(7.6
)
 
(6.6
)
Change in unrecognized tax benefit
25.6

 
45.8

 
(16.0
)
U.S. audit settlement, net

 
(83.2
)
 
(19.2
)
Permanent differences—net
1.2

 
4.7

 
10.6

Amortization on intercompany sale
5.7

 
5.7

 

Other
8.2

 
4.8

 
3.4

(Benefit) provision for income taxes
$
(259.5
)
 
$
(40.4
)
 
$
(26.1
)
Effective income tax rate
39.4
%
 
(29.1
)%
 
(11.2
)%

Significant components of deferred income tax assets and liabilities as of June 30, 2017 and 2016 are presented below:

June 30,
2017
 
June 30,
2016
Deferred income tax assets:
 
 
 
Inventories
$
11.7

 
$
19.3

Accruals and allowances
108.8

 
53.0

Sales returns
14.8

 
13.6

Share-based compensation
14.2

 
14.6

Employee benefits
141.2

 
64.8

Net operating loss carry forwards and tax credits
436.9

 
237.7

Other
40.7

 
23.8

Less: valuation allowances
(60.3
)
 
(179.2
)
Net deferred income tax assets
708.0

 
247.6

Deferred income tax liabilities:
 
 
 
Intangible assets
1,420.9

 
367.3

Property, plant and equipment
44.1

 
19.0

Unrealized gain
44.0

 
49.1

Licensing rights
30.4

 
26.6

Other
20.9

 
3.5

Deferred income tax liabilities
1,560.3

 
465.5

Net deferred income tax liabilities
$
(852.3
)
 
$
(217.9
)

Deferred tax assets relating to tax benefits of stock-based compensation have been reduced to reflect exercises of stock options to the extent recognized for financial statement purposes. Some exercises resulted in tax deductions in excess of previously recorded benefits at the time of grant. These excess tax benefits are not recognized in the deferred tax balances until the deductions reduce taxes payable. Accordingly, there is an additional $12.0 of net operating losses which are not reflected as part of the net deferred tax assets.
The expirations of tax loss carry forwards, amounting to $1,327.6 as of June 30, 2017, in each of the fiscal years ending June 30, are presented below:
Fiscal Year Ending June 30,
United States

Western Europe

Rest of World

Total
2018
$

 
$

 
$
48.6

 
$
48.6

2019

 

 
14.7

 
14.7

2020

 

 
74.9

 
74.9

2021

 
0.8

 
12.0

 
12.8

2022 and thereafter
813.5

 
239.8

 
123.3

 
1,176.6

Total
$
813.5

 
$
240.6

 
$
273.5

 
$
1,327.6


The total valuation allowances recorded are $60.3 and $179.2 as of June 30, 2017 and 2016, respectively. In fiscal 2017, the change in the valuation allowance was due primarily to a release in the U.S.
A reconciliation of the beginning and ending amount of UTBs is presented below:
 
Year Ended June 30,
 
2017
 
2016
 
2015
UTBs—July 1
$
228.9

 
$
342.6

 
$
400.5

Additions based on tax positions related to the current year
43.6

 
60.4

 
51.6

Additions for tax positions of prior years
0.4

 

 
6.4

Reductions for tax positions of prior years

 
(70.5
)
 
(60.3
)
Settlements
(1.5
)
 
(72.7
)
 
(29.7
)
Lapses in statutes of limitations
(13.2
)
 
(37.9
)
 
(14.2
)
Foreign currency translation
(0.3
)
 
7.0

 
(11.7
)
UTBs—June 30
$
257.9

 
$
228.9

 
$
342.6


As of June 30, 2017, the Company had $257.9 of UTBs of which $243.1 represents the amount that, if recognized, would impact the effective income tax rate in future periods. As of June 30, 2017 and 2016, the liability associated with UTBs, including accrued interest and penalties, is $154.6 and $131.9, respectively, which is recorded in Income and other taxes payable and Other non-current liabilities in the Consolidated Balance Sheets.
During fiscal 2017, the Company accrued interest of $1.4, while in fiscal 2016 and 2015 the Company accrued and released interest of $1.2 and $(4.4), respectively. During fiscal 2017, the Company accrued penalty of $0.1, while in fiscal 2016 and 2015 the Company accrued and released penalty of $0.1 and $(1.0), respectively. The total gross accrued interest and penalties recorded in the Other noncurrent liabilities in the Consolidated Balance Sheets related to UTBs as of June 30, 2017 and 2016 is $11.7 and $9.9, respectively.
The Company is present in approximately 55 tax jurisdictions, and at any point in time is subject to several audits at various stages of completion. As a result, the Company evaluates tax positions and establishes liabilities for UTBs that may be challenged by local authorities and may not be fully sustained, despite a belief that the underlying tax positions are fully supportable. UTBs are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law, and closing of statute of limitations. Such adjustments are reflected in the provision for income taxes as appropriate. In fiscal 2017 and 2016, the Company recognized a tax benefit of $12.3 and $51.4 respectively associated with the settlement of tax audits in multiple jurisdictions and the expiration of foreign and state statutes of limitation. The Company has open tax years ranging from 2009 and forward.
On the basis of information available at June 30, 2017, it is reasonably possible that a decrease of up to $10.1 in UTBs related to U.S. and foreign exposures may be necessary within the coming year. It is also possible the ongoing audits by tax authorities may result in increases or decreases to the balance of UTBs. Since it is common practice to extend audits beyond the Statute of Limitations, the Company is unable to predict the timing or conclusion of these audits and, accordingly, the Company is unable to estimate the amount of changes to the balance of UTBs that are reasonably possible at this time. However, the Company believes it has adequately provided for its UTBs for all open tax years in each tax jurisdiction.
It is the Company’s intention to permanently reinvest undistributed earnings and income from the Company’s foreign operations that have been generated through June 30, 2017, except where we are able to repatriate these earnings to the U.S. without material incremental tax expenditures. Accordingly, no provision has been made for U.S. income taxes on the remaining undistributed earnings of foreign subsidiaries as of June 30, 2017. Cumulative undistributed earnings of non-U.S. subsidiaries was $2,412.7 as of June 30, 2017. It is not practicable for the Company to determine the amount of additional income and withholding taxes that may be payable in the event the undistributed earnings are repatriated.